Table 4.
Cardiac risk score (0–19) | Cardiac risk score (20–29) | Cardiac risk score (≥30) | P for trend | ||
---|---|---|---|---|---|
Metabolic syndrome | Model 1 | 1 | 2.07 (1.59–2.69) | 2.83 (1.93–4.15) | <0.0001 |
Model 2 | 1 | 1.48 (1.11–1.99) | 1.50 (0.97–2.32) | 0.0117 | |
Model 3 | 1 | 1.47 (1.09–1.96) | 1.51 (0.98–2.34) | 0.0124 | |
Waist circumference (cm) | Model 1 | 1 | 2.59 (1.91–3.52) | 4.29 (2.57–7.15) | <0.0001 |
Model 2 | 1 | 1.43 (0.98–2.09) | 1.34 (0.72–2.50) | 0.1 | |
Model 3 | 1 | 1.38 (0.94–2.02) | 1.32 (0.70–2.47) | 0.1384 | |
HDL‐C (mmol/L) | Model 1 | 1 | 1.07 (0.79–1.46) | 1.45 (0.97–2.17) | 0.1015 |
Model 2 | 1 | 0.91 (0.66–1.26) | 1.00 (0.64–1.57) | 0.8594 | |
Model 3 | 1 | 0.91 (0.66–1.25) | 0.98 (0.63–1.54) | 0.7903 | |
FPG (mmol/L) | Model 1 | 1 | 1.76 (1.35–2.29) | 1.98 (1.37–2.85) | <0.0001 |
Model 2 | 1 | 1.57 (1.18–2.07) | 1.62 (1.08–2.43) | 0.0024 | |
Model 3 | 1 | 1.57 (1.18–2.07) | 1.64 (1.10–2.46) | 0.0021 | |
Triglycerides (mmol/L) | Model 1 | 1 | 1.35 (1.04–1.75) | 1.56 (1.08–2.24) | 0.0048 |
Model 2 | 1 | 1.01 (0.76–1.34) | 0.93 (0.61–1.40) | 0.7936 | |
Model 3 | 1 | 0.98 (0.74–1.31) | 0.93 (0.61–1.41) | 0.7453 | |
Hypertension (mmHg) | Model 1 | 1 | 1.39 (1.07–1.81) | 1.94 (1.31–2.86) | 0.0002 |
Model 2 | 1 | 1.18 (0.89–1.57) | 1.49 (0.97–2.28) | 0.0581 | |
Model 3 | 1 | 1.18 (0.89–1.56) | 1.51 (0.98–2.32) | 0.0524 |
Data are odds ratios (95% confidence interval) compared with cardiac risk score (0–19) group. Participants with abnormal values for Waist circumference, high‐density lipoprotein cholesterol (HDL‐C), fasting plasma glucose (FPG), triglycerides and hypertension (as defined in the metabolic syndrome) are defined as 0, and with normal values as 1. Participants without metabolic syndrome are defined as 0 and with metabolic syndrome as 1. Model 1 is unadjusted. Model 2 is adjusted for sex and body mass index. Model 3 is adjusted for sex, body mass index, current smoking and current drinking.